These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2540170)

  • 41. Regulation of brain fatty acid-binding protein expression by differential phosphorylation of nuclear factor I in malignant glioma cell lines.
    Bisgrove DA; Monckton EA; Packer M; Godbout R
    J Biol Chem; 2000 Sep; 275(39):30668-76. PubMed ID: 10896661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The cerebellum-enriched form of nuclear factor I is functionally different from ubiquitous nuclear factor I in glial-specific promoter regulation.
    Krebs CJ; Dey B; Kumar G
    J Neurochem; 1996 Apr; 66(4):1354-61. PubMed ID: 8627286
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Physical and functional interaction between viral and cellular proteins modulate JCV gene transcription.
    Safak M; Khalili K
    J Neurovirol; 2001 Aug; 7(4):288-92. PubMed ID: 11517404
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nuclear factor I family members regulate the transcription of surfactant protein-C.
    Bachurski CJ; Kelly SE; Glasser SW; Currier TA
    J Biol Chem; 1997 Dec; 272(52):32759-66. PubMed ID: 9407049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transcription of the JC virus archetype late genome: importance of the kappa B and the 23-base-pair motifs in late promoter activity in glial cells.
    Mayreddy RP; Safak M; Razmara M; Zoltick P; Khalili K
    J Virol; 1996 Apr; 70(4):2387-93. PubMed ID: 8642666
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mapping 5' termini of JC virus early RNAs.
    Kenney S; Natarajan V; Selzer G; Salzman NP
    J Virol; 1986 May; 58(2):651-4. PubMed ID: 3009875
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Negative regulation of the human polyomavirus BK enhancer involves cell-specific interaction with a nuclear repressor.
    Grinnell BW; Berg DT; Walls JD
    Mol Cell Biol; 1988 Aug; 8(8):3448-57. PubMed ID: 2850493
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BAG-1, a novel Bcl-2-interacting protein, activates expression of human JC virus.
    Devireddy LR; Kumar KU; Pater MM; Pater A
    J Gen Virol; 2000 Feb; 81(Pt 2):351-7. PubMed ID: 10644833
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of JCVL promoter function: evidence that a pentanucleotide "silencer" repeat sequence AGGGAAGGGA down-regulates transcription of the JC virus late promoter.
    Tada H; Lashgari MS; Khalili K
    Virology; 1991 Jan; 180(1):327-38. PubMed ID: 1845829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The JC virus minimal core promoter is glial cell specific in vivo.
    Krebs CJ; McAvoy MT; Kumar G
    J Virol; 1995 Apr; 69(4):2434-42. PubMed ID: 7884891
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recognition site of nuclear factor I, a sequence-specific DNA-binding protein from HeLa cells that stimulates adenovirus DNA replication.
    Leegwater PA; van Driel W; van der Vliet PC
    EMBO J; 1985 Jun; 4(6):1515-21. PubMed ID: 4040852
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hybrid genomes of the polyomaviruses JC virus, BK virus, and simian virus 40: identification of sequences important for efficient transformation.
    Bollag B; Chuke WF; Frisque RJ
    J Virol; 1989 Feb; 63(2):863-72. PubMed ID: 2536108
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction of a nuclear factor with the polyomavirus enhancer region.
    Ostapchuk P; Diffley JF; Bruder JT; Stillman B; Levine AJ; Hearing P
    Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8550-4. PubMed ID: 3022296
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NFI-Ski interactions mediate transforming growth factor beta modulation of human papillomavirus type 16 early gene expression.
    Baldwin A; Pirisi L; Creek KE
    J Virol; 2004 Apr; 78(8):3953-64. PubMed ID: 15047811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human polyomavirus JCV late leader peptide region contains important regulatory elements.
    Akan I; Sariyer IK; Biffi R; Palermo V; Woolridge S; White MK; Amini S; Khalili K; Safak M
    Virology; 2006 May; 349(1):66-78. PubMed ID: 16497349
    [TBL] [Abstract][Full Text] [Related]  

  • 56. JC virus enhancer-promoter active in human brain cells.
    Kenney S; Natarajan V; Strike D; Khoury G; Salzman NP
    Science; 1984 Dec; 226(4680):1337-9. PubMed ID: 6095453
    [TBL] [Abstract][Full Text] [Related]  

  • 57. JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy.
    White FA; Ishaq M; Stoner GL; Frisque RJ
    J Virol; 1992 Oct; 66(10):5726-34. PubMed ID: 1326640
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Host range bias of the JC virus mutant enhancer with DNA rearrangement.
    Shinohara T; Matsuda M; Yasui K; Yoshiike K
    Virology; 1989 May; 170(1):261-3. PubMed ID: 2541539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region.
    Jensen PN; Major EO
    J Neurovirol; 2001 Aug; 7(4):280-7. PubMed ID: 11517403
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Brd4 acetyllysine-binding protein is involved in activation of polyomavirus JC.
    Wollebo HS; Bellizzi A; Cossari DH; Salkind J; Safak M; White MK
    J Neurovirol; 2016 Oct; 22(5):615-625. PubMed ID: 27007123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.